Current Report Filing (8-k)
22 February 2023 - 01:19AM
Edgar (US Regulatory)
0000846475
false
0000846475
2023-02-16
2023-02-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 16, 2023
Zynex, Inc.
(Exact Name of Registrant as Specified in
its Charter)
Nevada |
001-38804 |
90-0275169 |
|
|
|
(State or other jurisdiction
of incorporation) |
Commission File
Number |
(I.R.S. Employer Identification
number) |
9655 Maroon Circle, Englewood, CO 80112
(Address of principal
executive offices) (Zip Code)
Registrant's telephone number, including area code: (800) 495-6670
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
Ticker symbol(s) |
Name of each exchange on which
registered |
Common Stock, $0.001 par value per share |
ZYXI |
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2).
Emerging growth company ¨
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
ITEM 8.01 OTHER EVENTS
On February 21, 2023,
the Company issued a press release announcing the lease of a new 41,000 square foot facility to accommodate Zynex Monitoring Solution’s
(ZMS) current and expected future growth. The new ZMS facility is located within a quarter mile of Zynex Medical
Headquarters on Maroon Drive in Englewood, Colorado, and the 66-month lease begins on July 1, 2023.
The full text of the
press release is furnished herewith as Exhibit 99.1.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
d) Exhibits.
The following exhibits are filed with this report.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: February 21, 2023
|
ZYNEX, INC. |
|
|
|
|
|
/s/ Dan Moorhead |
|
Dan Moorhead |
|
Chief Financial Officer |
Zynex (NASDAQ:ZYXI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Zynex (NASDAQ:ZYXI)
Historical Stock Chart
From Mar 2023 to Mar 2024